| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.28 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.27 | 0.4 |